Comparison of Intraparenchymal and Intradermal Injection for Identification of the Sentinel Node in Patients with Breast Cancer (Clinical Report)

Advertisement

Comparison of Intraparenchymal and Intradermal Injection for Identification of the Sentinel Node in Patients with Breast Cancer (Clinical Report)

Background: Sentinel lymph node (SLN) mapping with radioisotope and blue dye has been advocated for the staging of clinically negative axillae in patients with breast cancer. The optimal radiotracer injection technique is still being defined. This study compares the results of intraparenchymal and intradermal injection of technetium 99m (Tc 99m) sulfur colloid to establish an optimal method for SLN localization. Methods: Consecutive patients (n = 435) with clinically T0-2N0 breast cancer had SLN biopsy performed by a single surgeon. All patients but one received injections of both blue dye and Tc 99m sulfur colloid; one patient had injection of blue dye only and was excluded from analysis. Blue dye injections were intraparenchymal in all patients. The results of intraparenchymal (n = 107) and intradermal (n = 327) injections of radioisotope were compared for the following endpoints: 1) successful SLN identification, 2) false-negative rate, and 3) ratio of SLN/axillary background isotope counts.

Comparison of Intraparenchymal and Intradermal Injection for Identification of the Sentinel Node in Patients with Breast Cancer (Clinical Report)

Advertisement
Comparison of Intraparenchymal and Intradermal Injection for Identification of the Sentinel Node in Patients with Breast Cancer (Clinical Report) | | 4.5